Levonic

Levofloxacin, the active ingredient in Levonic, is a fluoroquinolone presented as an intravenous injection for systemic use. It is indicated for the treatment of bacterial infections such as community‑acquired pneumonia, urinary tract infections, and skin and soft‑tissue infections in adult patients.

GNH USA supplies Levonic as a licensed, GDP‑compliant product, delivering it to hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide from its EU‑origin market. The product meets European pharmacopeial standards and is manufactured under GMP conditions. It is available in single‑dose vials for convenient administration.

Levofloxacin is a fluoroquinolone antibacterial used to treat infections caused by susceptible bacteria.

- Community‑acquired pneumonia: effective in eradicating the causative bacterial pathogens and improving respiratory symptoms. - Urinary tract infection: provides bacterial clearance in the urinary tract and reduces infection signs. - Skin and soft‑tissue infection: eliminates pathogenic bacteria and promotes healing of infected skin lesions. - Complicated urinary tract infection: achieves bacterial eradication and alleviates systemic symptoms.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or swelling, especially in the Achilles. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reaction: anaphylaxis with hives, swelling, or breathing difficulty. - Clostridioides difficile colitis: severe diarrhea with abdominal pain. - Stevens‑Johnson syndrome: extensive skin blistering and mucosal involvement.

Levofloxacin should be used with caution in specific clinical situations.

- Renal impairment: adjust dosing in patients with severe renal dysfunction. - Elderly patients: monitor for increased risk of tendon injury and CNS effects. - Concomitant QT‑prolonging drugs: observe cardiac rhythm for arrhythmia risk. - History of tendon disorders: avoid or use only if benefits outweigh risks. - Pregnancy and lactation: assess risk–benefit as safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concurrent fluoroquinolones: increased risk of toxicity. - NSAIDs: heightened potential for central nervous system stimulation. - QT‑prolonging agents: may cause serious cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Antacids or mineral supplements (Al, Mg, Ca, Fe): may reduce levofloxacin absorption. - Warfarin: possible enhancement of anticoagulant effect; monitor INR. - Theophylline: potential increase in theophylline levels; watch for toxicity.